Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam Prophylaxis in Brain Tumor Resection
NCT05897658Phase 3Not yet recruiting
- Sponsor
- Hamilton Health Sciences
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levetiracetam in epilepsy, sponsored by Hamilton Health Sciences. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05897658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897658.